Telemedicine in Heart Failure; Treatment, Prognosis and Patient Experience

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Heart Failure
Interventions
DEVICE

Telemedicine

Patients receive equipment for report of vital signs and patient reported experience measures (PREMS), automatically transmitted via smartphone/bluetooth for six months (possible extension to 12 months in case of instability). A digital smartphone application is used for registration and transmission of data, including modes for asynchronous (chat) communication with the healthcare provider. Planned titration to OMT or diuretic adjustments may be done remotely depending on clinical assessment. The digital sensors include an electronic scale, pulse and blood pressure monitor for daily measurements by the patient.

Trial Locations (1)

41685

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Skaraborgs Hospital

UNKNOWN

collaborator

Southern Älvsborg Hospital

OTHER

lead

Sahlgrenska University Hospital

OTHER

NCT06237998 - Telemedicine in Heart Failure; Treatment, Prognosis and Patient Experience | Biotech Hunter | Biotech Hunter